)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Insight Molecular Diagnostics
Insight Molecular Diagnostics (IMDX) investor relations material
Insight Molecular Diagnostics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary30 Apr, 2026
Executive summary
Annual meeting scheduled for June 11, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials online and may request paper or email copies at no charge.
Voting matters and shareholder proposals
Election of four director nominees to serve until the 2027 annual meeting or until successors are elected.
Ratification of CBIZ CPAS P.C. as independent auditor for the year ending December 31, 2026.
Advisory vote on named executive officer compensation for the year ended December 31, 2025.
Approval of an amendment to increase shares authorized under the 2018 Equity Incentive Plan by 1,750,000, totaling 5,550,000 shares.
Board recommends voting "FOR" all director nominees and proposals 2, 3, and 4.
Board of directors and corporate governance
Four director nominees: Joshua Riggs, Andrew Arno, Andrew J. Last, and Louis E. Silverman.
Directors to serve until the 2027 annual meeting or until successors are elected and qualified.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Insight Molecular Diagnostics
- Proxy covers director elections, auditor ratification, compensation, and equity plan expansion.IMDX
Proxy filing30 Apr 2026 - GraftAssure's decentralized PCR test drives transplant diagnostics innovation and market expansion.IMDX25th Annual Needham Virtual Healthcare Conference15 Apr 2026
- Transplant monitoring market disruption accelerates with Bio-Rad partnership and clinical milestones.IMDXInvestor presentation13 Apr 2026
- In-house dd-cfDNA testing enables faster, broader access and improved transplant outcomes.IMDXKOL event12 Apr 2026
- FDA submission and strong clinical data drive commercialization and growth in transplant diagnostics.IMDXQ4 202526 Mar 2026
- Decentralized transplant diagnostics drive rapid adoption and growth in a $2B+ global market.IMDXInvestor presentation26 Mar 2026
- Q2 2025 revenue up 398% to $518,000; FDA submission and commercial launch remain on track.IMDXQ2 202519 Feb 2026
- Q3 revenue dropped, losses widened, but new funding and Bio-Rad deal support future growth.IMDXQ3 202419 Feb 2026
- Q4 2024 revenue hit $1.5M; Bio-Rad partnership and FDA submission drive future growth.IMDXQ4 202419 Feb 2026
Next Insight Molecular Diagnostics earnings date
Q1 202611 May, 2026
Insight Molecular Diagnostics
Next Insight Molecular Diagnostics earnings date
Q1 202611 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage